Calumet Specialty Products Partners (CLMT) reported a Q2 net loss Friday of $0.48 per diluted unit, widening from a loss of $0.27 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.55.
Sales for the quarter ended June 30 were $1.13 billion, up from $1.02 billion a year earlier.
Analysts surveyed by Capital IQ expected $889.2 million.
Shares of the company were up 5.2% in recent premarket activity.
Price: 12.40, Change: +0.61, Percent Change: +5.17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments